APA (7th ed.) Citation

Shufen Wang, Yan Ma, Yi Hu, Xia Zhao, Yilin Li, Shuming Ouyang, & Guifang Luo. (2023). FOXD3 confers chemo-sensitivity in ovarian cancer through a miR-335/DAAM1/myosin II axis-dependent mechanism. BMC.

Chicago Style (17th ed.) Citation

Shufen Wang, Yan Ma, Yi Hu, Xia Zhao, Yilin Li, Shuming Ouyang, and Guifang Luo. FOXD3 Confers Chemo-sensitivity in Ovarian Cancer Through a MiR-335/DAAM1/myosin II Axis-dependent Mechanism. BMC, 2023.

MLA (9th ed.) Citation

Shufen Wang, et al. FOXD3 Confers Chemo-sensitivity in Ovarian Cancer Through a MiR-335/DAAM1/myosin II Axis-dependent Mechanism. BMC, 2023.